Investment House LLC increased its position in shares of Clorox Co (NYSE:CLX) by 1.7% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 41,354 shares of the company’s stock after buying an additional 675 shares during the period. Investment House LLC’s holdings in Clorox were worth $6,332,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Mn Services Vermogensbeheer B.V. raised its stake in Clorox by 0.6% during the first quarter. Mn Services Vermogensbeheer B.V. now owns 70,968 shares of the company’s stock worth $11,388,000 after buying an additional 400 shares during the last quarter. SlateStone Wealth LLC grew its holdings in Clorox by 13.6% in the first quarter. SlateStone Wealth LLC now owns 5,043 shares of the company’s stock worth $809,000 after purchasing an additional 605 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its holdings in Clorox by 1.1% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 35,017 shares of the company’s stock worth $5,619,000 after purchasing an additional 384 shares during the period. Sadoff Investment Management LLC grew its holdings in Clorox by 0.7% in the first quarter. Sadoff Investment Management LLC now owns 127,494 shares of the company’s stock worth $20,458,000 after purchasing an additional 945 shares during the period. Finally, Raymond James Financial Services Advisors Inc. grew its holdings in Clorox by 47.0% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 112,626 shares of the company’s stock worth $18,075,000 after purchasing an additional 36,029 shares during the period. 75.88% of the stock is owned by institutional investors and hedge funds.
A number of equities research analysts have commented on CLX shares. Deutsche Bank upgraded shares of Clorox from a “sell” rating to a “hold” rating and set a $139.00 price target for the company in a report on Thursday, May 2nd. ValuEngine cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Wells Fargo & Co restated a “hold” rating and issued a $153.00 price target on shares of Clorox in a report on Thursday, August 1st. UBS Group raised their price target on shares of Clorox from $110.00 to $128.00 and gave the stock a “sell” rating in a report on Friday, August 2nd. Finally, Bank of America restated a “neutral” rating and issued a $154.00 price target (down from $165.00) on shares of Clorox in a report on Thursday, May 2nd. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company. Clorox has an average rating of “Hold” and a consensus price target of $154.07.
In other news, SVP Diego J. Barral sold 1,987 shares of Clorox stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $157.59, for a total transaction of $313,131.33. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director A D. David Mackay sold 3,400 shares of Clorox stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The disclosure for this sale can be found here. Insiders have sold 25,786 shares of company stock valued at $4,054,776 over the last quarter. Corporate insiders own 1.40% of the company’s stock.
NYSE:CLX traded down $2.12 during trading hours on Tuesday, reaching $160.01. The company had a trading volume of 27,616 shares, compared to its average volume of 1,073,986. The firm has a market cap of $20.23 billion, a price-to-earnings ratio of 25.32, a P/E/G ratio of 5.06 and a beta of 0.37. The business’s 50-day simple moving average is $159.23 and its two-hundred day simple moving average is $155.71. Clorox Co has a twelve month low of $141.53 and a twelve month high of $167.70. The company has a quick ratio of 0.55, a current ratio of 0.91 and a debt-to-equity ratio of 4.09.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The firm had revenue of $1.63 billion during the quarter, compared to analysts’ expectations of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The business’s revenue was down 3.8% on a year-over-year basis. During the same period last year, the company earned $1.66 earnings per share. As a group, equities analysts predict that Clorox Co will post 6.4 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st were issued a dividend of $1.06 per share. This is a boost from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.65%. The ex-dividend date of this dividend was Tuesday, July 30th. Clorox’s dividend payout ratio (DPR) is currently 67.09%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Further Reading: Technical Analysis of Stocks and What It Means
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.